• Je něco špatně v tomto záznamu ?

Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment

L. Hroch, O. Benek, P. Guest, L. Aitken, O. Soukup, J. Janockova, K. Musil, V. Dohnal, R. Dolezal, K. Kuca, TK. Smith, F. Gunn-Moore, K. Musilek,

. 2016 ; 26 (15) : 3675-8. [pub] 20160530

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023918

Grantová podpora
NV15-28967A MZ0 CEP - Centrální evidence projektů

Amyloid-beta peptide (Aβ) has been recognized to interact with numerous proteins, which may lead to pathological changes in cell metabolism of Alzheimer's disease (AD) patients. One such known metabolic enzyme is mitochondrial amyloid-binding alcohol dehydrogenase (ABAD), also known as 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10). Altered enzyme function caused by the Aβ-ABAD interaction, was previously shown to cause mitochondrial distress and a consequent cytotoxic effect, therefore providing a feasible target in AD drug development. Based on previous frentizole derivatives studies, we report two novel series of benzothiazolyl ureas along with novel insights into the structure and activity relationships for inhibition of ABAD. Two compounds (37, 39) were identified as potent ABAD inhibitors, where compound 39 exhibited comparable cytotoxicity with the frentizole standard; however, one-fold higher cytotoxicity than the parent riluzole standard. The calculated and experimental physical chemical properties of the most potent compounds showed promising features for blood-brain barrier penetration.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023918
003      
CZ-PrNML
005      
20201029153833.0
007      
ta
008      
170720s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bmcl.2016.05.087 $2 doi
035    __
$a (PubMed)27287370
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hroch, Lukas $u Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Department of Pharmaceutical Chemistry and Drug Control, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic; University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
245    10
$a Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment / $c L. Hroch, O. Benek, P. Guest, L. Aitken, O. Soukup, J. Janockova, K. Musil, V. Dohnal, R. Dolezal, K. Kuca, TK. Smith, F. Gunn-Moore, K. Musilek,
520    9_
$a Amyloid-beta peptide (Aβ) has been recognized to interact with numerous proteins, which may lead to pathological changes in cell metabolism of Alzheimer's disease (AD) patients. One such known metabolic enzyme is mitochondrial amyloid-binding alcohol dehydrogenase (ABAD), also known as 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10). Altered enzyme function caused by the Aβ-ABAD interaction, was previously shown to cause mitochondrial distress and a consequent cytotoxic effect, therefore providing a feasible target in AD drug development. Based on previous frentizole derivatives studies, we report two novel series of benzothiazolyl ureas along with novel insights into the structure and activity relationships for inhibition of ABAD. Two compounds (37, 39) were identified as potent ABAD inhibitors, where compound 39 exhibited comparable cytotoxicity with the frentizole standard; however, one-fold higher cytotoxicity than the parent riluzole standard. The calculated and experimental physical chemical properties of the most potent compounds showed promising features for blood-brain barrier penetration.
650    _2
$a 3-hydroxyacyl-CoA-dehydrogenasy $x antagonisté a inhibitory $x metabolismus $7 D015094
650    _2
$a Alzheimerova nemoc $x farmakoterapie $7 D000544
650    _2
$a zvířata $7 D000818
650    _2
$a benzothiazoly $x chemie $x farmakologie $7 D052160
650    _2
$a CHO buňky $7 D016466
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a Cricetulus $7 D003412
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    12
$a racionální návrh léčiv $7 D015195
650    _2
$a inhibitory enzymů $x chemická syntéza $x chemie $x farmakologie $7 D004791
650    _2
$a lidé $7 D006801
650    _2
$a molekulární struktura $7 D015394
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a močovina $x analogy a deriváty $x chemie $x farmakologie $7 D014508
655    _2
$a časopisecké články $7 D016428
700    1_
$a Benek, Ondrej $u University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic; University of Defence, Faculty of Military Health Sciences, Department of Toxicology, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic.
700    1_
$a Guest, Patrick $u University of St. Andrews, School of Biology, Medical and Biological Sciences Building, North Haugh, St. Andrews KY16 9TF, United Kingdom.
700    1_
$a Aitken, Laura $u University of St. Andrews, School of Biology, Medical and Biological Sciences Building, North Haugh, St. Andrews KY16 9TF, United Kingdom. $7 gn_A_00002727
700    1_
$a Soukup, Ondrej $u University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
700    1_
$a Janockova, Jana $u University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
700    1_
$a Musil, Karel $u University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic; University of Hradec Kralove, Faculty of Science, Department of Chemistry, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic.
700    1_
$a Dohnal, Vlastimil $u University of Hradec Kralove, Faculty of Science, Department of Chemistry, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic.
700    1_
$a Dolezal, Rafael $u University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic; University of Hradec Kralove, Faculty of Informatics and Management, Center for Basic and Applied Research, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic.
700    1_
$a Kuca, Kamil $u University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic; University of Hradec Kralove, Faculty of Science, Department of Chemistry, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic.
700    1_
$a Smith, Terry K $u Biomedical Science Research Complex, University of St. Andrews, North Haugh, St. Andrews KY16 9ST, United Kingdom.
700    1_
$a Gunn-Moore, Frank $u University of St. Andrews, School of Biology, Medical and Biological Sciences Building, North Haugh, St. Andrews KY16 9TF, United Kingdom.
700    1_
$a Musilek, Kamil $u University Hospital, Biomedical Research Center, Sokolska 581, 500 05 Hradec Kralove, Czech Republic; University of Hradec Kralove, Faculty of Science, Department of Chemistry, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic. Electronic address: kamil.musilek@gmail.com.
773    0_
$w MED00000770 $t Bioorganic & medicinal chemistry letters $x 1464-3405 $g Roč. 26, č. 15 (2016), s. 3675-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27287370 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20201029153830 $b ABA008
999    __
$a ok $b bmc $g 1239599 $s 984831
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 26 $c 15 $d 3675-8 $e 20160530 $i 1464-3405 $m Bioorganic & medicinal chemistry letters $n Bioorg Med Chem Lett $x MED00000770
GRA    __
$a NV15-28967A $p MZ0
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Možnosti archivace